NOTARZT, Table of Contents NOTARZT 2021; 37(02): 72DOI: 10.1055/a-1372-0252 Journal Club Tranexamsäure – vom Wundermittel zum rationalen Einsatz Recommend Article Abstract Buy Article Full Text References Literatur 1 CRASH-2 trial collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010; 376: 23-32 doi:10.1016/S0140-6736(10)60835-5 2 The CRASH-3 trial collaborators. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomized, placebo-controlled trial. Lancet 2019; 394: 1713-1723 doi:10.1016/S0140-6736(19)32233-0 3 Lier H, Maegele M, Shander A. Tranexamic Acid for Acute Hemorrhage: A Narrative Review of Landmark Studies and a Critical Reappraisal of Its Use Over the Last Decade. Anesth Analg 2019; 129: 1574-1584 doi:10.1213/ANE.0000000000004389 4 TXA – nicht mit der Giesskanne! Teil 3. 21.05.2018. Im Internet (Stand: 09.02.2021): https://news-papers.eu/?p=7235 5 Knapp J. CRASH-3: TXA jetzt bei SHT? 17.10.2019. Im Internet (Stand: 09.02.2021): https://news-papers.eu/?p=10405
